Allogene Therapeutics Inc
(ALLO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,931 | 61,904 | 74,357 | 96,041 | 84,514 |
| Marketable Securities | 361,293 | 455,416 | 477,872 | 394,451 | 364,536 |
| TOTAL | $481,465 | $528,824 | $569,061 | $513,028 | $469,744 |
| Non-Current Assets | |||||
| PPE Net | 109,849 | 112,839 | 114,442 | 117,216 | 120,200 |
| Investments And Advances | 53,912 | 76,468 | 99,154 | 211,333 | 298,297 |
| Other Non-Current Assets | 101,645 | 103,448 | 104,915 | 106,067 | 76,391 |
| TOTAL | $265,406 | $292,755 | $318,511 | $434,616 | $494,888 |
| Total Assets | $746,871 | $821,579 | $887,572 | $947,644 | $964,632 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,688 | 13,890 | 11,045 | 9,713 | 8,708 |
| Accrued Expenses | 44,624 | 39,743 | 36,938 | 34,360 | 27,763 |
| TOTAL | $59,585 | $53,728 | $48,872 | $44,909 | $36,877 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 273 | 95 | 889 | 836 | 406 |
| Other Non-Current Liabilities | 95,024 | 100,969 | 98,739 | 100,786 | 72,525 |
| TOTAL | $95,024 | $100,969 | $98,739 | $100,786 | $72,525 |
| Total Liabilities | $154,609 | $154,697 | $147,611 | $145,695 | $109,402 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 145,842 | 144,497 | 144,210 | 143,807 | 143,600 |
| Common Shares | 146 | 144 | 144 | 144 | 143 |
| Retained earnings | -1,334,684 | -1,234,968 | -1,141,133 | -1,057,985 | -983,198 |
| Other shareholders' equity | -5,934 | -9,926 | -12,958 | -11,472 | -9,249 |
| TOTAL | $592,262 | $666,882 | $739,961 | $801,949 | $855,230 |
| Total Liabilities And Equity | $746,871 | $821,579 | $887,572 | $947,644 | $964,632 |